Nova Patents
AT359793T

2-methyl-thieno-benzodiazepine formulation

Abstract

The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.

Term

Term ended

Expired 24 March 2019, 7.5 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

105 members in 35 offices

This recordMember, by publication datePriority claim25 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
16376898United States of AmericaA
16376998United States of AmericaA

Members105

Family members, oldest first
DocumentOfficeKind
CA2304568A1CanadaA1
WO9916313A1World Intellectual Property Organization (WIPO)A1
AU9591498AAustraliaA
NO20001631D0NorwayD0
CA2344873A1CanadaA1
WO0018408A1World Intellectual Property Organization (WIPO)A1
AU3362799AAustraliaA
PE20000353A1PeruA1
NO20001631LNorwayL
EP1018880A1European Patent Office (EPO)A1
BR9813228ABrazilA
CZ20001162A3CzechiaA3
ID25533AIndonesiaA
CN1271251AChinaA
EA200000381A1Eurasian Patent Organization (EAPO)A1
HRP20000181A2CroatiaA2
US6169084B1United States of AmericaB1
PL339864A1PolandA1
NO20011583D0NorwayD0
NO20011583LNorwayL
KR20010030774ARepublic of KoreaA
IL135295D0IsraelD0
HU0004534A2HungaryA2
HUP0004534A2HungaryA2
BR9914156ABrazilA
TR200000812T2TürkiyeT2
EP1119359A1European Patent Office (EPO)A1
KR20010075458ARepublic of KoreaA
TR200100885T2TürkiyeT2
ID29574AIndonesiaA
JP2001517685AJapanA
EA200100406A1Eurasian Patent Organization (EAPO)A1
AR018171A1ArgentinaA1
CN1320038AChinaA
EP1119359A4European Patent Office (EPO)A4
CZ20011149A3CzechiaA3
HU0103636A2HungaryA2
HUP0103636A2HungaryA2
SK4162001A3SlovakiaA3
IL141766D0IsraelD0
PL346981A1PolandA1
ZA200102231BSouth AfricaB
HRP20010238A2CroatiaA2
EA002580B1Eurasian Patent Organization (EAPO)B1
HK1041199A1Hong Kong, ChinaA1
JP2002525330AJapanA
AU752552B2AustraliaB2
NZ503641ANew ZealandA
HU0004534A3HungaryA3
HUP0004534A3HungaryA3
EA002825B1Eurasian Patent Organization (EAPO)B1
US2003027816A1United States of AmericaA1
NZ510208ANew ZealandA
AU759751B2AustraliaB2
HU0103636A3HungaryA3
HUP0103636A3HungaryA3
US6617321B2United States of AmericaB2
AU752552CAustraliaC
TW577890BTaiwan Province of ChinaB
CN1146422CChinaC
US2004097489A1United States of AmericaA1
EP1119359B1European Patent Office (EPO)B1
AT267602TAustriaT
ATE267602T1AustriaT1
UA66872C2UkraineC2
DE69917663D1GermanyD1
DK1119359T3DenmarkT3
PT1119359EPortugalE
EP1468689A1European Patent Office (EPO)A1
ES2221376T3SpainT3
SI1119359T1SloveniaT1
HK1041199BHong Kong, ChinaB
DE69917663T2GermanyT2
UA73715C2UkraineC2
KR100537713B1Republic of KoreaB1
CN1239158CChinaC
HRP20010238B1CroatiaB1
EP1018880A4European Patent Office (EPO)A4
HRP20000181B1CroatiaB1
KR100618012B1Republic of KoreaB1
IL135295AIsraelA
MY126476AMalaysiaA
IL141766AIsraelA
EP1468689B1European Patent Office (EPO)B1
AT359793TThis recordAustriaT
ATE359793T1AustriaT1
DE69935873D1GermanyD1
PT1468689EPortugalE
DK1468689T3DenmarkT3
SI1468689T1SloveniaT1
SK285944B6SlovakiaB6
ES2285294T3SpainT3
US7303764B2United States of AmericaB2
DE69935873T2GermanyT2
PL196821B1PolandB1
CA2304568CCanadaC
CZ300725B6CzechiaB6
GEP20094818BGeorgiaB
NO328243B1NorwayB1
JP2010138208AJapanA
Showing 100 of 105